sagent pharmaceuticals inc
(SGNT:Consolidated Issue Listed on NASDAQ Global Select )
Mary Taylor Behrens
Director, Chairperson of Compensation Committee and Member of Corporate Governance & Nominating Committee, Sagent Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 14 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Ms. Mary Taylor Behrens served as the President of Newfane Advisors, Inc since November 2004. Ms. Behrens has particular knowledge and experience in human resources, strategic planning and leadership of complex organizations. She formed Newfane Advisors after 13 years as a Senior Executive with Merrill Lynch & Co., Inc. with responsibilities that included serving as the Head of Human Resources and Head, Americas Region of Merrill Lynch Investment Managers. From February ...
1901 North Roselle RoadPhone: 847-908-1600
Schaumburg, Illinois 60195
Board Members Memberships*
Director, Member of Compensation Committee and Member of Quality Committee
Director, Chairperson of Compensation Committee and Member of Corporate Governance & Nominating Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Friedhelm Blobel Ph.D.||Chief Executive Officer, President, Executive Director and Member of Business Development Committee|
SciClone Pharmaceuticals, Inc.
|Aijaz Tobaccowalla||Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee|
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals Inc.
|Douglas L. Drysdale||Chairman, Chief Executive Officer and President|
Pernix Therapeutics Holdings, Inc.
|--||Compensation as of Fiscal Year 2013.|